Ignite Creation Date:
2024-05-06 @ 7:07 AM
Last Modification Date:
2024-10-26 @ 11:45 AM
Study NCT ID:
NCT02476955
Status:
TERMINATED
Last Update Posted:
2020-09-30
First Post:
2015-06-10
Brief Title:
Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole
Sponsor:
ArQule Inc a subsidiary of Merck Sharp Dohme LLC a subsidiary of Merck Co Inc Rahway NJ USA
Organization:
ArQule Inc a subsidiary of Merck Sharp Dohme LLC a subsidiary of Merck Co Inc Rahway NJ USA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-10
First Submit QC Date:
June 17 2015
Study First Post Date:
2015-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-28
Last Update Post Date:
2020-09-30
Last Update Post Date Type:
ACTUAL